Posts Posts by: "Zoe Freeman"

The agreement – a £2 million two-year collaboration co-funded by Innovate UK – is to explore a next generation gene and cell therapy manufacturing platform for clinical and commercial applications. London, UK – 11 August 2017: Oxford BioMedica plc (“Oxford BioMedica” or “the Group”) (LSE:OXB), a leading gene and cell therapy group, has announced it…(Read More)

Tim Fell, Synthace, and Richard Hammond, Cambridge Consultants

Collaboration to boost adoption of Antha, a new platform for the engineering of biological systems April 4, 2017 – Product design and development firm Cambridge Consultants is joining forces with innovative software company Synthace in an ambitious bid to unlock the full potential of biology to address many of the global challenges facing the world.…(Read More)